JAK inhibition as a new treatment strategy for patients with COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic continues to spread globally. The rapid dispersion of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 drives an urgent need for effective treatments, especially for patients who develop severe pneumonia. The excessive...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jin, Zhou, Chi, Deng, Jinniu, Zhou, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250821/
https://www.ncbi.nlm.nih.gov/pubmed/35787993
http://dx.doi.org/10.1016/j.bcp.2022.115162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250821/
https://www.ncbi.nlm.nih.gov/pubmed/35787993
http://dx.doi.org/10.1016/j.bcp.2022.115162

Ejemplares similares